0.55 -0.03 (-5.17%)
RGN
Stock Details
Last Trade:0.55 Change:-0.03 (-5.17%) Prev Close:0.58 Open: 0.58 Days Range:0.52 – 0.59 52 Week Range: 0.31 - 1.95 Volume:69575 P/E: N/AEPS:-0.15
View AllRecent Alerts 02/10/10
Recent Alert on 01/21/10 at 8:34am
Regenerx Biopharma (RGN) Moving Maryland HQ
Regenerx Biopharma (RGN) Moving Maryland HQ
Regenerx Biopharmaceuticals, Inc. (AMEX: RGN) announced today that it is moving its corporate headquarters from Bethesda, Maryland to the Maryland I-270 Technology Corridor in Rockville, Maryland, effective January 22, 2010. The company's offices... Read More
Recent Alert on 01/12/10 at 10:24am
Morning Movers 01/12: ZRBA, EFOI, VLNC, CDII, YRCW, ERI Higher; GAP, ATSI, MFLX, CACH Lower
Morning Movers 01/12: ZRBA, EFOI, VLNC, CDII, YRCW, ERI Higher; GAP, ATSI, MFLX, CACH Lower
Recent Alert on 01/12/10 at 8:55am
NIH Awards $5M to Regenerx Biopharma (RGN) Collaborators for Tb4 Study
NIH Awards $5M to Regenerx Biopharma (RGN) Collaborators for Tb4 Study
Recent Alert on 01/12/10 at 8:55am
NIH Awards $5M to Regenerx Biopharma (RGN) Collaborators for Tb4 Study
NIH Awards $5M to Regenerx Biopharma (RGN) Collaborators for Tb4 Study
Recent Alert on 12/09/09 at 10:20am
Morning Movers 12/09: RNWK, EFJI, S, HITK, VCI, COO Higher; ECA, RGEN, MOV, MW, PLAB Lower
Morning Movers 12/09: RNWK, EFJI, S, HITK, VCI, COO Higher; ECA, RGEN, MOV, MW, PLAB Lower
View AllRecent Press Releases
Press Release on 02/08/10 at 8:30am
Researchers Report Elevated Levels of Tb4 Levels Predict Patient Survival in Hepatitis B Virus-related Liver Failure
Researchers Report Elevated Levels of Tb4 Levels Predict Patient Survival in Hepatitis B Virus-related Liver Failure
View AllRecent SEC Filings
No Recent SEC Filings Available